[go: up one dir, main page]

NO20013102L - Gener, proteiner og deres anvendelse - Google Patents

Gener, proteiner og deres anvendelse

Info

Publication number
NO20013102L
NO20013102L NO20013102A NO20013102A NO20013102L NO 20013102 L NO20013102 L NO 20013102L NO 20013102 A NO20013102 A NO 20013102A NO 20013102 A NO20013102 A NO 20013102A NO 20013102 L NO20013102 L NO 20013102L
Authority
NO
Norway
Prior art keywords
genes
proteins
Prior art date
Application number
NO20013102A
Other languages
English (en)
Other versions
NO20013102D0 (no
Inventor
Martin John Glenton Hughes
Joseph David Santangelo
Jonathan Douglas Lane
Robert Feldman
Joanne Christine Moore
Richard James Dobson
Rebecca Kerry Wilson
Paul Everest
Gordon Dougan
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828355.9A external-priority patent/GB9828355D0/en
Priority claimed from GBGB9828350.0A external-priority patent/GB9828350D0/en
Priority claimed from GBGB9828356.7A external-priority patent/GB9828356D0/en
Priority claimed from GBGB9828349.2A external-priority patent/GB9828349D0/en
Priority claimed from GBGB9828354.2A external-priority patent/GB9828354D0/en
Priority claimed from GBGB9828359.1A external-priority patent/GB9828359D0/en
Priority claimed from GBGB9828357.5A external-priority patent/GB9828357D0/en
Priority claimed from GBGB9828353.4A external-priority patent/GB9828353D0/en
Priority claimed from GBGB9828345.0A external-priority patent/GB9828345D0/en
Priority claimed from GBGB9828352.6A external-priority patent/GB9828352D0/en
Priority claimed from GBGB9900085.3A external-priority patent/GB9900085D0/en
Priority claimed from GBGB9900083.8A external-priority patent/GB9900083D0/en
Priority claimed from GBGB9900082.0A external-priority patent/GB9900082D0/en
Priority claimed from GBGB9900084.6A external-priority patent/GB9900084D0/en
Priority claimed from GBGB9900086.1A external-priority patent/GB9900086D0/en
Priority claimed from GBGB9901922.6A external-priority patent/GB9901922D0/en
Priority claimed from GBGB9901916.8A external-priority patent/GB9901916D0/en
Publication of NO20013102D0 publication Critical patent/NO20013102D0/no
Application filed by Microscience Ltd filed Critical Microscience Ltd
Publication of NO20013102L publication Critical patent/NO20013102L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
NO20013102A 1998-12-22 2001-06-21 Gener, proteiner og deres anvendelse NO20013102L (no)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
GBGB9828349.2A GB9828349D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828354.2A GB9828354D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828359.1A GB9828359D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828357.5A GB9828357D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828353.4A GB9828353D0 (en) 1998-12-22 1998-12-22 Protein and compositions containig it
GBGB9828356.7A GB9828356D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828345.0A GB9828345D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828355.9A GB9828355D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828352.6A GB9828352D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828350.0A GB9828350D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9900085.3A GB9900085D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900083.8A GB9900083D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900082.0A GB9900082D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900084.6A GB9900084D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900086.1A GB9900086D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9901922.6A GB9901922D0 (en) 1999-01-28 1999-01-28 Protein and compositions containing it
GBGB9901916.8A GB9901916D0 (en) 1999-01-28 1999-01-28 Protein and compositions containing it
PCT/GB1999/004377 WO2000037646A2 (en) 1998-12-22 1999-12-22 Group b streptococcus proteins, and their use

Publications (2)

Publication Number Publication Date
NO20013102D0 NO20013102D0 (no) 2001-06-21
NO20013102L true NO20013102L (no) 2001-08-10

Family

ID=27585888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013102A NO20013102L (no) 1998-12-22 2001-06-21 Gener, proteiner og deres anvendelse

Country Status (22)

Country Link
US (3) US6812021B1 (no)
EP (3) EP1141308B1 (no)
JP (1) JP2002533083A (no)
KR (3) KR100790653B1 (no)
CN (1) CN101066447A (no)
AP (1) AP1502A (no)
AT (1) ATE353367T1 (no)
AU (1) AU776735B2 (no)
CA (1) CA2354135A1 (no)
CY (1) CY1106559T1 (no)
CZ (1) CZ20012172A3 (no)
DK (1) DK1141308T3 (no)
EA (1) EA004444B1 (no)
ES (1) ES2281977T3 (no)
HU (1) HUP0104825A3 (no)
NO (1) NO20013102L (no)
NZ (3) NZ512297A (no)
OA (1) OA11734A (no)
PL (1) PL201887B1 (no)
PT (1) PT1141308E (no)
SI (1) SI1141308T1 (no)
WO (1) WO2000037646A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1141308B1 (en) 1998-12-22 2007-02-07 Microscience Limited Group b streptococcus proteins, and their use
US6890539B2 (en) * 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
JP2002533065A (ja) * 1998-12-22 2002-10-08 マイクロサイエンス リミテッド 外表面たんぱく質、それらの遺伝子、およびそれらの用途
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
EP1360324A2 (en) 2000-08-31 2003-11-12 Mayo Foundation For Medical Education And Research Detection of varicella-zoster virus
GB0021977D0 (en) 2000-09-07 2000-10-25 Pyrosequencing Ab Method of sequencing DNA
US7691571B2 (en) 2001-01-31 2010-04-06 Mayo Foundation For Medical Education And Research Detection of bordetella
US7074598B2 (en) 2002-09-25 2006-07-11 Mayo Foundation For Medical Education And Research Detection of vancomycin-resistant enterococcus spp.
US7365176B2 (en) 2002-09-26 2008-04-29 Mayo Foundation For Medical Education And Research Detection of Epstein-Barr virus
JP2006514636A (ja) * 2002-12-02 2006-05-11 バイオシネクサス インコーポレーテッド 抗ブドウ球菌療法およびワクチンの標的としての壁テイコイン酸
US7427475B2 (en) 2003-11-18 2008-09-23 Mayo Foundation For Medical Education And Research Detection of group B streptococcus
WO2008152448A2 (en) * 2006-12-21 2008-12-18 Emergent Product Development Uk Limited Streptococcus proteins, and their use in vaccination
AU2013261006B2 (en) 2012-05-18 2016-07-14 Tata Consultancy Services Limited Method and system for determining and implementing a viable containment design of a data center
CN106822885B (zh) 2017-02-16 2020-06-30 清华大学 肺炎链球菌疫苗

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328996A (en) 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
AU668908B2 (en) 1992-01-08 1996-05-23 Rockefeller University, The Multifunctional surface protein of streptococci
DE69432658T2 (de) * 1993-03-19 2004-04-08 Gunnar Lindahl Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
US6015889A (en) 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
US6420135B1 (en) 1996-10-31 2002-07-16 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
US7196164B2 (en) 1997-07-08 2007-03-27 Human Genome Sciences, Inc. Secreted protein HHTLF25
US7153952B1 (en) * 1997-07-02 2006-12-26 sanofi pasteur limited/sanofi pasteur limitée Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6380370B1 (en) 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
ATE347600T1 (de) 1998-02-20 2006-12-15 Id Biomedical Corp Gruppe b-streptococcus antigene
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
AU763770B2 (en) 1998-07-14 2003-07-31 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
WO2000006736A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
IL142831A0 (en) 1998-10-30 2002-03-10 Janssen Pharmaceutica Nv An unusual retrotransposon from the yeast candida albicans
WO2000025728A2 (en) 1998-11-05 2000-05-11 United States Government As Represented By The Secretary Of The Navy Chromosome 2 sequence of the human malaria parasite plasmodium falciparum and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents
EP1141308B1 (en) 1998-12-22 2007-02-07 Microscience Limited Group b streptococcus proteins, and their use
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
JP2002533065A (ja) 1998-12-22 2002-10-08 マイクロサイエンス リミテッド 外表面たんぱく質、それらの遺伝子、およびそれらの用途
WO2000061621A2 (en) 1999-04-09 2000-10-19 Heska Corporation Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
US6605709B1 (en) 1999-04-09 2003-08-12 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
AU1478301A (en) 1999-11-09 2001-06-06 Glaxo Group Limited Staphylococcus epidermidis nucleic acids and proteins
JP2004507217A (ja) 2000-04-11 2004-03-11 アンスティテュ・パストゥール リステリア菌ゲノム、ポリペプチドおよびその使用
US6974667B2 (en) 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
CA2425303A1 (en) 2000-10-27 2002-05-02 John Telford Nucleic acids and proteins from streptococcus groups a & b
WO2002077183A2 (en) 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP2258842A1 (en) 2001-04-16 2010-12-08 Wyeth Holdings Corporation Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
US7314624B2 (en) 2001-06-05 2008-01-01 The Regents Of The University Of Michigan Nanoemulsion vaccines
CA2452720C (en) 2001-07-26 2012-04-17 Chiron S.R.L. Vaccines comprising aluminium adjuvants and histidine
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
ES2504166T3 (es) 2002-09-13 2014-10-08 Novartis Vaccines And Diagnostics, Inc. Vacuna de estreptococo del grupo B
WO2004099242A2 (en) 2003-05-07 2004-11-18 Intercell Ag Streptococcus agalactiae antigens i + ii
EP1663303B1 (en) 2003-09-15 2011-05-04 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions for streptococcus agalactiae
EP1817432A2 (en) 2004-10-05 2007-08-15 Wyeth a Corporation of the State of Delaware Probe arrays for detecting multiple strains of different species
EP1828231A2 (en) 2004-12-22 2007-09-05 Novartis Vaccines and Diagnostics, Inc. Group b streptococcus

Also Published As

Publication number Publication date
PL349320A1 (en) 2002-07-15
AP2001002189A0 (en) 2001-06-30
DK1141308T3 (da) 2007-06-04
WO2000037646A3 (en) 2000-10-26
EP1757696A3 (en) 2008-10-29
CZ20012172A3 (cs) 2001-11-14
HUP0104825A3 (en) 2008-04-28
CN101066447A (zh) 2007-11-07
NZ535122A (en) 2006-04-28
EA004444B1 (ru) 2004-04-29
US20090274717A1 (en) 2009-11-05
KR100790653B1 (ko) 2007-12-31
US20080181908A1 (en) 2008-07-31
NZ512297A (en) 2003-12-19
EA200100700A1 (ru) 2001-12-24
WO2000037646A2 (en) 2000-06-29
JP2002533083A (ja) 2002-10-08
KR20070101197A (ko) 2007-10-16
NO20013102D0 (no) 2001-06-21
EP2105504A2 (en) 2009-09-30
PT1141308E (pt) 2007-05-31
KR20010089844A (ko) 2001-10-11
US7419672B2 (en) 2008-09-02
EP1141308B1 (en) 2007-02-07
SI1141308T1 (sl) 2007-08-31
ES2281977T3 (es) 2007-10-01
AU776735B2 (en) 2004-09-23
EP1757696A2 (en) 2007-02-28
US6812021B1 (en) 2004-11-02
EP2105504A3 (en) 2010-01-06
HK1039353A1 (en) 2002-04-19
CY1106559T1 (el) 2012-01-25
EP1141308A2 (en) 2001-10-10
ATE353367T1 (de) 2007-02-15
PL201887B1 (pl) 2009-05-29
NZ526879A (en) 2004-12-24
CA2354135A1 (en) 2000-06-29
OA11734A (en) 2005-05-12
HUP0104825A2 (hu) 2002-04-29
AU1878000A (en) 2000-07-12
KR20080050550A (ko) 2008-06-09
AP1502A (en) 2005-12-20

Similar Documents

Publication Publication Date Title
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
DE69840172D1 (de) Rna exportelement
NO972983L (no) Sulfonamider og deres anvendelse
NO20011956L (no) Substituerte fenylderivater, deres fremstilling og anvendelse
FI103614B1 (fi) Vaiheistus- ja balansointielin
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20013102L (no) Gener, proteiner og deres anvendelse
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
NO20005502D0 (no) Polymerer og deres anvendelse
EP1078639A4 (en) STABLE GENERATION
NO20013101D0 (no) Ytre overflateproteiner, deres gener og deres anvendelse
NO20030821D0 (no) Gener og proteiner, og deres anvendelse
NO20020919D0 (no) Irenprotein, dets fremstilling og anvendelse
NO20003268L (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse
TR199900944A3 (tr) Rafinoz sintaz genleri ve kullanimlari
GB0105922D0 (en) Genes and proteins, and their use
AP2005003413A0 (en) Genes and proteins, and their use.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application